Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

2.

Pathology and diagnosis of SMARCB1-deficient tumors.

Margol AS, Judkins AR.

Cancer Genet. 2014 Sep;207(9):358-64. doi: 10.1016/j.cancergen.2014.07.004. Epub 2014 Aug 1. Review.

PMID:
25246033
3.
4.

Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility.

Kim HJ, Kim MH, Kwon J, Kim JY, Park K, Ro JY.

Ann Diagn Pathol. 2012 Oct;16(5):411-5. doi: 10.1016/j.anndiagpath.2011.04.002. Epub 2011 Jul 2. Review.

PMID:
21724432
5.

INI1-deficient tumors: diagnostic features and molecular genetics.

Hollmann TJ, Hornick JL.

Am J Surg Pathol. 2011 Oct;35(10):e47-63. doi: 10.1097/PAS.0b013e31822b325b. Review.

PMID:
21934399
6.

SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.

Agaimy A, Rau TT, Hartmann A, Stoehr R.

Am J Surg Pathol. 2014 Jul;38(7):910-20. doi: 10.1097/PAS.0000000000000173. Review.

PMID:
24503755
7.

Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.

Savage N, Linn D, McDonough C, Donohoe JM, Franco A, Reuter V, Biddinger PW, Eaton KW, Biegel JA, Sharma S.

Ann Diagn Pathol. 2012 Dec;16(6):504-7. doi: 10.1016/j.anndiagpath.2011.04.008. Epub 2011 Jul 19. Review.

8.

Selected topics in the pathology of epithelioid soft tissue tumors.

Folpe AL.

Mod Pathol. 2014 Jan;27 Suppl 1:S64-79. doi: 10.1038/modpathol.2013.175. Review.

9.

[Epithelioid sarcoma: morphologic variants and differential diagnosis].

Mentzel T.

Pathologe. 2010 Mar;31(2):135-41. doi: 10.1007/s00292-009-1250-0. Review. German.

PMID:
19997734
10.

The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.

Agaimy A.

Adv Anat Pathol. 2014 Nov;21(6):394-410. doi: 10.1097/PAP.0000000000000038. Review.

PMID:
25299309
11.

Epithelioid sarcoma.

Armah HB, Parwani AV.

Arch Pathol Lab Med. 2009 May;133(5):814-9. doi: 10.1043/1543-2165-133.5.814. Review.

PMID:
19415960
12.

Biology and Treatment of Rhabdoid Tumor.

Geller JI, Roth JJ, Biegel JA.

Crit Rev Oncog. 2015;20(3-4):199-216. Review.

PMID:
26349416
13.

Pediatric-type sarcomas in adult patients.

Montesco MC, Alaggio R, Ninfo V.

Semin Diagn Pathol. 2003 Nov;20(4):324-37. Review.

PMID:
14694983
14.

Risk assignment in pediatric soft-tissue sarcomas: an evolving molecular classification.

Qualman SJ, Morotti RA.

Curr Oncol Rep. 2002 Mar;4(2):123-30. Review.

PMID:
11822984
15.

Malignant rhabdoid tumor of the colon: report of a case.

Nakamura I, Nakano K, Nakayama K, Ishii Y, Ohta K, Takahashi M, Yamada T, Yamaguchi K, Sakuma H, Tsuchiya A, Takenoshita S.

Surg Today. 1999;29(10):1083-7. Review.

PMID:
10554335
16.

Genetic and molecular abnormalities in tumors of the bone and soft tissues.

Letson GD, Muro-Cacho CA.

Cancer Control. 2001 May-Jun;8(3):239-51. Review.

PMID:
11378650
17.

[Extrarenal rhabdoid tumor: A review of literature and a report of cases with atypical morphology].

Mitrofanova AM, Roshchin VY, Kislyakov AN, Abramov DS, Rogozhin DV, Konovalov DM.

Arkh Patol. 2017;79(3):34-41. doi: 10.17116/patol201779334-41. Review. Russian.

PMID:
28631714
18.

Modern pathological evaluation of soft tissue sarcoma specimens and its potential role in soft tissue sarcoma research.

Zhang P, Brooks JS.

Curr Treat Options Oncol. 2004 Dec;5(6):441-50. Review.

PMID:
15509478
19.

Doing more with less: New markers for sarcoma diagnosis and their applicability to cytology specimens.

Dodd LG, Ware P, Duncan D, Hertel J.

Diagn Cytopathol. 2016 Apr;44(4):351-60. doi: 10.1002/dc.23428. Epub 2016 Jan 18. Review.

PMID:
26780171
20.

Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Mariño-Enríquez A, Bovée JV.

Surg Pathol Clin. 2016 Sep;9(3):457-73. doi: 10.1016/j.path.2016.04.009. Review.

Supplemental Content

Support Center